Literature DB >> 304772

Bone disease in children with chronic renal failure: therapy with 1alpha-hydroxyvitamin D3.

R J Postlethwaite, I B Houston.   

Abstract

Results of 1alpha-hydroxyvitamin D3 therapy in twelve children with renal bone disease are described. Nine of the twelve children showed a good response to 0.05--0.08 microgram/kg/day. Hypercalcaemia was the only side effect and proved easy to manage because of the short half-life of 1alpha-OHD3.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 304772     DOI： 10.1111/j.1365-2265.1977.tb03371.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


  2 in total

1.  Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis.

Authors:  Larry A Greenbaum; Ryszard Grenda; Ping Qiu; Irene Restaino; Amy Wojtak; Ana Paredes; Nadine Benador; Joel Z Melnick; Laura A Williams; Isidro B Salusky
Journal:  Pediatr Nephrol       Date:  2005-03-23       Impact factor: 3.714

2.  [Renal osteodystrophy in children. Therapy with 1,25-dihydroxy-cholechalciferol (author's transl)].

Authors:  M Bulla; G Delling; G Benz-Bohm; G J Stock; A Sánchez de Reutter; R Ziegler; H Lühmann; M Severin; E Kalbitzer; C Manegold
Journal:  Klin Wochenschr       Date:  1980-05-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.